Abstract
Helicobacter pylori (HP) infection initiates and promotes gastric carcinogenesis. ONECUT2 shows promise for tumor diagnosis, prognosis, and treatment. This study explored ONECUT2’s role and the specific mechanism underlying HP infection-associated gastric carcinogenesis to suggest a basis for targeting ONECUT2 as a therapeutic strategy for gastric cancer (GC). Multidimensional data supported an association between ONECUT2, HP infection, and GC pathogenesis. HP infection upregulated ONECUT2 transcriptional activity via NFκB. In vitro and in vivo experiments demonstrated that ONECUT2 increased the stemness of GC cells. ONECUT2 was also shown to inhibit PPP2R4 transcription, resulting in reduced PP2A activity, which in turn increased AKT/β-catenin phosphorylation. AKT/β-catenin phosphorylation facilitates β-catenin translocation to the nucleus, initiating transcription of downstream stemness-associated genes in GC cells. HP infection upregulated the reduction of AKT and β-catenin phosphorylation triggered by ONECUT2 downregulation via ONECUT2 induction. Clinical survival analysis indicated that high ONECUT2 expression may indicate poor prognosis in GC. This study highlights a critical role played by ONECUT2 in promoting HP infection-associated GC by enhancing cell stemness through the PPP2R4/AKT/β-catenin signaling pathway. These findings suggest promising therapeutic strategies and potential targets for GC treatment.
Similar content being viewed by others
Introduction
Gastric cancer (GC) is one of the leading malignancy-related causes of mortality worldwide [1]. The major risk factors for GC include Helicobacter pylori (HP) infection, advanced age, excessive salt intake, and inadequate consumption of fruits and vegetables [2]. HP infection was the predominant environmental contributor. However, the exact mechanism through which HP initiates GC development remains unclear. Therefore, identifying effective strategies to stop the HP-mediated induction and progression of GC, deepening our understanding of GC pathogenesis, and identifying novel therapeutic and preventive targets are essential for improving GC treatment outcomes. Studies have suggested that HP infection facilitates the establishment of a chronic inflammatory microenvironment in the stomach [3,4,5,6]. Inflammatory factors released under these conditions can induce degeneration, proliferation, and abnormal differentiation of gastric epithelial cells, thereby promoting tumorigenesis [7, 8]. Long-term persistence of this chronic inflammatory microenvironment may induce a subset of cells to transform into cancer stem cells, driving tumor initiation and progression [9, 10].
According to the inflammation-atrophy-metaplasia-carcinoma theory of GC progression [11], long-term chronic HP infection may affect cancer stem cell populations in several ways, including altering the differentiation state of epithelial cells, triggering epigenetic changes such as DNA methylation, and initiating inflammatory and immune responses in the microenvironment [12,13,14,15,16]. Cancer stem cells exhibit exceptional self-renewal and proliferative capabilities and play critical roles in tumor initiation, maintenance, and progression. The regulatory mechanism by which inflammation affects GC stem cells is extremely complex, and the identification of key regulatory molecules may reveal promising targets for GC prevention and treatment.
We identified significant correlations between ONECUT2, HP infection, and GC. These relationships were uncovered by analyzing data collected from our research center and public databases, including single-cell RNA sequencing, spatial transcriptomics, high-throughput RNA sequencing, etc. ONECUT2, a member of the ONECUT transcription factor family, is characterized by a cut domain [17]. This transcription factor is predominantly expressed in the gallbladder, duodenum, liver, and small intestine and is minimally expressed in the brain, pancreas, stomach, and testes [17]. ONECUT2 is critical in various biological processes and diseases, including liver development, insulin secretion, spinal neuron development, and acquisition and maintenance of cancer stemness [17,18,19,20,21,22,23]. In recent years, research on ONECUT2 has intensified, deepening our understanding of its effects on cell fate determination and disease onset and progression. Accumulating evidence indicates that ONECUT2 expression significantly influences the development and progression of malignant tumors [24,25,26], suggesting that ONECUT2 may have significant potential for tumor diagnosis, prognosis, and treatment. Despite these findings, the role and specific mechanisms of action of ONECUT2 in HP infection-related GC remain unclear. We aimed to investigate the role and mechanism of ONECUT2 in developing HP infection-related GC and provide a scientific basis for the therapeutic targeting of ONECUT2 to treat this disease.
Materials and methods
Human samples
Human gastric carcinoma samples were collected from the Fujian Medical University Union Hospital, China. Written informed consent was obtained from all the participants. This study analyzed gastric cancer tissue from 349 patients collected from April 2013 to December 2022, including 75 cases for RT-qPCR, 92 cases for immunoblotting, 36 cases for RNA sequencing, two cases for spatial transcriptomics, nine cases for single-cell RNA sequencing, and 135 cases for tissue microarray. The inclusion criteria were as follows: (a) histologically diagnosed gastric cancer; (b) no history of the patients had received preoperative radiotherapy, chemotherapy, or other biological agents; (c) complete clinicopathologic data; and (d) more than 5 years of follow-up for the tissue microarray cases. This study’s design and reporting procedures were approved by the Institutional Review Board of Fujian Medical University Union Hospital (IRB number:2021KJT028-01).
Mice
Mice were maintained at the Fujian Medical University animal facility in accordance with institutional guidelines. Ethical approval was obtained from the Fujian Medical University Animal Conservation and Use Committee (FJMU IACUC 2021-J-0065).
Statistical analyses
Detailed descriptions of our materials, methods, and statistical analyses are provided in the “Supplementary Methods”. Full and uncropped western blots are presented in the Supplementary Material. The primer sequences are provided in Supplementary Table 4.
Results
ONECUT2 is associated with HP infection and GC
To identify genes associated with HP infection and GC, we combined RNA-seq data from 36 GC cases and their matched para-carcinoma tissue from our research center with GC sequencing data from The Cancer Genome Atlas (TCGA) to comprise our human GC cohort. Our mouse cohort was assembled from RNA-seq data from five HP-infected and five uninfected mice, together with data from TNF KO and BALB/c conditionally mutant mouse models of inflammation-related GC (dataset GSE43145) obtained from the Gene Expression Omnibus (GEO). After overlapping, 130 upregulated and 184 downregulated DEGs in the human GC cohort and 42 upregulated and 42 downregulated differential expressed genes (DEGs) in the mouse cohort were obtained in our analysis. Untimately, we identified two commonly upregulated genes (ONECUT2 and CLDN7) and six commonly downregulated genes by overlapping human and mouse GC cohorts (Fig. 1A). Further TCGA GC database validation confirmed a significant association between ONECUT2 expression and disease-free survival (DFS) (P = 0.024). In contrast, the associations for the remaining seven genes were not statistically significant or showed an inverse trend (Supplementary Fig. 1A). Therefore, we investigated the role of ONECUT2 in HP infection and GC development.
Our review of the TCGA public database revealed a significant upregulation of ONECUT2 mRNA expression in most cancers, including gastric adenocarcinoma (STAD), compared to the corresponding non-tumor tissue (Supplementary Fig. 1B). These findings implicated ONECUT2 as a potential player in developing multiple tumor types. Further analysis using non-paired and paired GC datasets from the GEO and mouse GC datasets consistently showed increased ONECUT2 mRNA expression in cancerous tissue (Supplementary Fig. 1C–E). Furthermore, within the human HP-infected GC cell line (GSE70394) and HP-infected healthy gastric epithelial cell line (GSE74577) datasets, ONECUT2 was significantly overexpressed in HP-infected samples compared with those from healthy tissue (Supplementary Fig. 1F). These results indicate a close association between ONECUT2, HP infection, and the pathogenesis of GC.
To further clarify the mechanism by which ONECUT2 mediates HP-associated gastric carcinogenesis, we performed single-cell RNA sequencing of nine human STAD samples (two with and seven without HP infection) (Fig. 1B, C, and Supplementary Table 1). After excluding poor-quality cells, 56,693 cells were analyzed. ONECUT2 expression significantly increased in HP-infected human GC samples (Fig. 1D, E). These cell clusters were categorized into ten different cell types (Fig. 1F and Supplementary Fig. 2A, B), with ONECUT2 expression predominantly elevated in epithelial cells compared with other cell populations (Fig. 1G). We identified epithelial cell clusters and classified them as ONECUT2-positive or ONECUT2-negative based on the presence or absence of ONECUT2 expression. Genomic Set Enrichment Analysis (GSEA) revealed enrichment of the TNFα signaling pathway via the NFκB and mTORC1 signaling gene clusters within cancer cells expressing ONECUT2 (Fig. 1H and Supplementary data 2).
RNA-seq data from 36 GC cases showed high ONECUT2 mRNA levels in human GC tissue (Fig. 1I). We also obtained 75 and 92 sets of fresh GC and adjacent non-tumor tissue samples, respectively, from our research center. These samples were subjected to RT-qPCR and immunoblotting (Fig. 1J–M). Our data confirmed that ONECUT2 mRNA transcript levels were significantly elevated in a significant proportion of GC patients (65.33%; 49/75). We also observed increased ONECUT2 protein expression in GC patients (67.4%; 62/92). These results indicated a potential oncogenic role of ONECUT2 in HP-associated GC.
HP infection upregulates ONECUT2 via NFκB
We investigated the association between HP infection and ONECUT2 expression in vivo and in vitro. Our experiments involved co-cultivation of a pathogenic HP strain (ATCC 43054) with AGS and NCI-N87 GC cell lines characterized by high ONECUT2 protein expression (Supplementary Fig. 3A). Data from HP-infected cells showed a time-dependent increase in the protein expression of CagA, a marker of HP infection, in parallel with an upward trend in ONECUT2 protein expression and mRNA transcription (Fig. 2A, B). Our in vivo study using HP-infected mice confirmed these findings; the duration of HP infection was positively correlated with ONECUT2 mRNA and protein expression in gastric tissue (Fig. 2C). Together, these results indicated the potential role of HP in enhancing ONECUT2 mRNA and protein expression.
To further investigate the spatial transcriptional regulation mechanism by which HP infection mediates gastric carcinogenesis via ONECUT2, we performed 10x Genomics Visium experiments on GC tissue sections from one HP-infected patient (Po1, Fig. 2D and Supplementary Table 2) and one uninfected patient (Ne1, Fig. 2E). From the Po1 and Ne1 sections, we obtained 4954 and 4854 spots, respectively, each representing 2–10 cells. As expected, ONECUT2 mRNA expression was higher in HP-infected GC tissue than in uninfected ones (Fig. 2F).
Our single-cell RNA sequencing analyses revealed enrichment of ONECUT2-positive tumor cells within clusters displaying TNFα signaling via NFκB (Fig. 1H). The spatial transcriptome results further revealed that RELA (a protein-coding gene of the NFκB subunit) expression was higher in HP-infected GC tissue than in uninfected tissue (Fig. 2G). In a time gradient assay, p-NFκB (s536) gradually increased with increasing duration of HP infection (Fig. 2A). These findings indicate NFκB’s link to ONECUT2 protein expression and its role in mediating HP infection-induced gastric carcinogenesis. To elucidate the spatial transcriptional relationship between ONECUT2 and RELA, spots from HP-infected and uninfected sections were grouped into 10 and 14 clusters using Seurat graph-based clustering analysis. Despite the challenge of identifying the exact composition of each cluster due to tumor infiltration and the potential mixing of different cells in the tumor microenvironment, clusters with higher ONECUT2 expression (clusters 0, 1, 2, 3, 4, and 9 in the HP section and cluster 1 in the uninfected section) were consistently associated with increased RELA expression in HP-infected and uninfected GC tissue (Fig. 2D, E).
Our previous research suggests that HP may modulate downstream targets via NFκB signaling [27]. We thus induced NFκB (p65) overexpression in GC cells or used an NFκB pathway activator, specifically 100 ng/ml TNF-α protein, and observed increased levels of phosphorylated NFκB (p-NFκB at s536), ONECUT2 mRNA, and ONECUT2 protein. These increases correlated with the elevated intensity of p65-overexpressing plasmid transfection and an increased duration of NFκB pathway activation (Fig. 3A–C). In contrast, a marked decrease in ONECUT2 mRNA and protein was observed upon application of 5 ng/ml of BAY protein (an NFκB pathway inhibitor) (Fig. 3D). These data confirm that HP infection can modulate ONECUT2 protein expression via the NFκB pathway.
NFκB is a transcription factor that primarily regulates downstream targets by modulating transcription. We used the JASPAR (http://jaspar.genereg.net/) website to predict two major NFκB binding sites within the ONECUT2 gene regulatory region (Fig. 3E) and constructed luciferase reporter plasmids using these sequences (Supplementary Fig. 3B–E). After evaluating NFκB (p65) in the GC cell lines AGS and NCI-N87 by overexpression, TNF-α-mediated activation, and induction of NFκB upregulation by HP infection, we performed dual-luciferase reporter assays. In GC cells transfected with ONECUT2 wild-type luciferase reporter plasmids, NFκB overexpression and NFκB activation via TNF-α or HP infection activated transcription from the ONECUT2 promoter (Fig. 3F–H). However, in GC cells transfected with ONECUT2 mutation (MU1, MU2 and MU1+2) luciferase reporter plasmids, overexpression of NFκB, activation of NFκB by TNF-α, or HP infection significantly decreased ONECUT2 promoter transcriptional activity (Fig. 3F–H). Together, these results demonstrate that HP infection upregulates ONECUT2 protein expression through NFκB, activating ONECUT2 gene transcription.
ONECUT2 promotes increased stemness in GC cells
To investigate ONECUT2 oncogenic mechanisms, we analyzed RNA-seq sequencing data (Supplementary data 1) from a GC cell line (NCI-N87) with ONECUT2 gene silencing and a negative control using the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. ONECUT2 was associated with signaling pathways that regulate cell stemness (Fig. 4A). In vitro experiments showed that compared with 2D GC cell culture, the expression of ONECUT2 protein and stemness-related markers CD44, SOX9, SOX2, and LGR4 simultaneously increased in 3D tumor stem cell spheroid culture (Fig. 4B). Overexpression or downregulation of ONECUT2 increased or decreased the expression of stemness markers, respectively (Fig. 4C), as confirmed at the mRNA level (Fig. 4D). In single-cell RNA sequencing data from nine patients with GC, these stemness markers were also highly expressed in epithelial cells (Supplementary Fig. 4A–D). Further analyses of spatial transcriptomic data revealed an increasing trend in these four stemness markers in HP-infected GC tissue in the Po1 and Ne1 sections (Supplementary Fig. 5A–D), and the Mki67 mRNA level was also elevated in HP-infected GC tissue (Supplementary Fig. 4G).
Human GC organoids were infected with lentiviruses designed to overexpress or downregulate ONECUT2 expression. ONECUT2 overexpression resulted in greater numbers of human GC organoids with increased diameters, whereas organoids infected with lentiviruses that downregulated ONECUT2 exhibited restricted growth (Fig. 4E–G). Immunofluorescence staining and the results of mRNA expression suggested increased expression of the stemness markers CD44 and SOX9 with ONECUT2 overexpression and decreased expression when ONECUT2 was downregulated (Fig. 4H, I). Evidence from both colony formation and cell proliferation assays supported the hypothesis that ONECUT2 stimulates AGS cell proliferation (Supplementary Figs. 6A–C). Our invasion and migration experiments consistently revealed the role of ONECUT2 in enhancing the invasive and migratory potentials of AGS cells (Supplementary Fig. 7A). Consistent with these findings, 3D spheroid experiments showed an increase in the size and number of spheroids, along with increased CD44 and SOX9 expression, when ONECUT2 was overexpressed. Conversely, the downregulation of ONECUT2 resulted in the absence of spheroids and a marked reduction in CD44 and SOX9 expression (Supplementary Figs. 6D–I).
During in vivo experiments, we identified a role for ONECUT2 in promoting the development of subcutaneous tumors in mouse models (Supplementary Fig. 6J). Using extreme limiting dilution analysis, we observed a markedly increased tumorigenic frequency in the ONECUT2-overexpressing cohort compared with the control cohort (1/10,844 vs. 1/104,377, P < 0.001). In contrast, the downregulation of ONECUT2 significantly reduced the tumorigenic frequency compared with the control group (1/448,139 vs. 1/83,322, P = 0.003) (Fig. 4J–L). Following the growth curves of tumor volumes within the highest cell count groups (n = 5), we found that ONECUT2 overexpression correlated with a significant increase in tumor volume compared with the control group. In contrast, its downregulation resulted in a significant decrease (Fig. 4M). Our mouse lung metastasis model further demonstrated that ONECUT2 facilitated lung metastasis (Supplementary Figs. 7B–C). Collectively, these findings highlight ONECUT2’s ability to enhance the stemness of GC cells.
ONECUT2 promotes increased stemness in GC cells via PPP2R4/AKT/β-catenin
To clarify the mechanism by which ONECUT2 enhances the stemness of GC cells, we performed RNA-seq analysis. Our analysis revealed a significant association between ONECUT2, PI3K/AKT, and other cancer-related pathways (Supplementary Fig. 8A). Single-cell RNA-seq analysis revealed the enrichment of mTORC1 signaling gene clusters in tumor cells expressing ONECUT2 (Fig. 1H), and AKT1 expression was observed in epithelial cells (Supplementary Fig. 4E). Therefore, AKT has been investigated as a potential therapeutic target. Using the TCGA public database, the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (GO-KEGG), and FC enrichment analyses revealed a significant correlation between ONECUT2 and the PI3K-AKT pathway (Fig. 5A and Supplementary Fig. 8B–D). Phosphatase microarray results showed that ONECUT2 downregulation in GC cells resulted in concomitant downregulation of several phosphatases, including GSK3β and AKT at both T308 and S473, compared with that in the control group (Fig. 5B). These results suggested a possible link between ONECUT2-induced stemness enhancement in GC cells and AKT signaling.
Analysis of proteins associated with the AKT pathway in GC cells overexpressing or downregulating ONECUT2 found that ONECUT2 can inhibit PP2A phosphatase activity and increase AKT(S473)/β-catenin(S552) phosphorylation, resulting in detectable changes in genes whose transcription is upregulated downstream of β-catenin, including CCND1 and the stemness-related factor LGR4 (Figs. 5C, 4C). Complementary single-cell RNA sequencing and spatial transcriptome analyses revealed increased CCND1 mRNA expression in epithelial cells and HP-infected GC tissue (Supplementary Fig. 4F, H). Notably, ONECUT2 possesses potential binding sites for the PPP2R4 subunit of PP2A, as indicated in the JASPAR database (Fig. 5D). A subsequent dual-luciferase reporter assay validated these sites’ functionality, showing that ONECUT2 can repress PPP2R4 transcription (Fig. 5E and Supplementary Fig. 3F–G), in turn decreasing PP2A activity and increasing AKT(S473)/β-catenin(S552) phosphorylation.
β-catenin becomes transcriptionally active by translocation to the nucleus. Data obtained from nuclear-cytoplasmic fractionation experiments showed that in NCI-N87 and AGS GC cell lines, ONECUT2 overexpression promotes β-catenin phosphorylation at S552, leading to nuclear accumulation of β-catenin. In contrast, when ONECUT2 is downregulated, β-catenin phosphorylation at S552 is inhibited, decreasing nuclear S552-phosphorylated β-catenin levels (Fig. 5F). Nuclear translocation experiments indicate that upon ONECUT2 overexpression, the cytoplasmic-to-nuclear shuttling of β-catenin is enhanced, leading to its nuclear localization. This process is attenuated in the nuclei of catenin cells in which ONECUT2 expression is suppressed, resulting in decreased levels of β-catenin (Fig. 5G). These results demonstrate that ONECUT2 can downregulate PPP2R4 transcription, thereby decreasing PP2A activity, leading to increased AKT(S473)/β-catenin(S552) phosphorylation, which promotes translocation of β-catenin to the nucleus to initiate transcription of downstream genes associated with stemness.
To determine whether this pathway is influenced by HP infection, we used HP to infect GC cells in which ONECUT2 expression was downregulated. Intriguingly, our results indicated that HP infection upregulated the reduction of AKT(S473) and β-catenin(S552) phosphorylation triggered by ONECUT2 downregulation via ONECUT2 induction (Fig. 5H). These observations provide strong evidence that the increase in ONECUT2 induced by HP infection enhances GC cell stemness through the PPP2R4/AKT/β-catenin signaling pathway, thereby promoting GC initiation and progression.
ONECUT2 is an independent prognostic factor in GC
To elucidate the relationship between ONECUT2 and GC prognosis, we performed immunohistochemical staining of paraffin-embedded tissue microarrays from 135 patients with GC at our center and examined the association between ONECUT2 staining intensity and survival rates. General clinicopathological characteristics of the patients are presented in Supplementary Table 3. High ONECUT2 expression was significantly associated with HP infection (Cramer’s V-test =0.418, P < 0.001). Figure 6A–B show representative images of ONECUT2 staining with different intensities, including negative controls. Our results showed that ONECUT2 was overexpressed in 56.30% of GC tissue, with expression levels in tumor tissue exceeding those in adjacent non-tumor tissue (Fig. 6C). Survival analyses suggested that patients with high ONECUT2 expression in GC tissue had lower overall survival rates than those with low-expression levels. The 5-year survival rate was significantly higher in the low-expression group (75.4%) than in the high-expression group (52.4%) (P < 0.05) (Fig. 6D). Consistent with our findings, analyses of the public GEO databases (GSE84433 and GSE34942) showed a significantly lower overall survival rate in patients with high ONECUT2 expression than in those with low expression (P < 0.05) (Fig. 6E). In addition, the 5-year survival rate was significantly higher in the non-HP infection group (72.5%) than in the HP infection group (51.3%) (P < 0.05) (Fig. 6F). Univariate and multivariate Cox regression analyses indicated that ONECUT2 served as an independent prognostic factor for 5-year overall survival in GC (HR = 2.144, 95% CI:1.080–4.255, P = 0.029) (Fig. 6G). In summary, our results demonstrated that high ONECUT2 expression may indicate poor prognosis in GC. Given the role of ONECUT2 in the pathogenesis of HP infection-related GC, we propose ONECUT2 as a potential therapeutic target for this GC subtype.
Discussion
GC is a complex disease involving multiple genetic and environmental factors. Although the role of HP infection in the development and progression of GC is an area of ongoing investigation, the precise mechanism through which HP infection is associated with GC remains largely unknown. It is believed that this disease develops and progresses through multiple pathways. In this study, we identified a strong correlation among ONECUT2 transcription factors, HP infection, gastric tumorigenesis, and GC prognosis by analyzing single-cell RNA sequencing, spatial transcriptomics, high-throughput data from multiple sources, and fresh GC tissue samples. Our results suggest that HP infection triggers gastric tumorigenesis by upregulating the expression of ONECUT2.
The role of ONECUT2, a multifunctional transcription factor, in tumor pathogenesis is currently under investigation. Previous studies have suggested that ONECUT2 modulates tumor cell proliferation, migration, and differentiation by orchestrating key transcription factors and signaling pathways. In prostate cancer, ectopic ONECUT2 expression, in conjunction with hypoxia, inhibits androgen signaling and induces neuroendocrine plasticity, thereby promoting prostate neuroendocrine cell proliferation [28, 29]. ONECUT2 has been implicated in the regulation of epithelial-mesenchymal transition (in colorectal cancer) by controlling the expression of E-cadherin and vimentin, thereby enhancing colorectal cancer cell invasiveness and metastatic potential [30, 31]. Following chemotherapy for breast cancer, ONECUT2 induces tumor stemness and triggers the expression of stem cell-related genes, including SOX9, SOX2, and NOTCH1, thereby contributing to chemoresistance [25]. In lung cancer, ONECUT2 promotes stem cell properties and affects the progression of RAS-driven tumors [32, 33]. Furthermore, ONECUT2 promotes GC progression via epigenetic modifications [34, 35]. Despite these findings, the precise relationship between ONECUT2 and GC, as well as its association with HP infection, remains unclear. Therefore, a deeper exploration of the specific roles and mechanisms of ONECUT2 in HP infection-related GC may pave the way for the development of innovative therapeutic and preventive strategies.
In this study, we established an experimental paradigm using GC cells infected with carcinogenic HP strains, as well as a mouse model of HP infection. Using these models, we showed both in vitro and in vivo that HP infection upregulated ONECUT2 expression. This upregulation is accompanied by increased phosphorylation of the inflammatory marker NFκB, which is recognized as a key indicator of HP infection [36, 37]. This finding was further supported by single-cell RNA sequencing and GC spatial transcriptomics data from both HP–infected and uninfected GC patients. Previous studies suggested that HP infection is a major contributor to GC development, either directly or indirectly through inflammation [6, 38]. The inflammatory response induced by HP infection often involves the transcription factor NFκB, an observation consistent with our preliminary studies illustrating the ability of HP to manipulate downstream target pathways via NFκB. NFκB plays a central role in several cellular processes, including immunity, inflammation, and cell apoptosis [39, 40]. Upon activation, NFκB translocates to the nucleus to stimulate the transcription and expression of a number of genes. Thus, we postulated that increased ONECUT2 protein expression may be facilitated by transcriptional regulation mediated by HP infection. Our experimental data, which include changes in ONECUT2 expression levels following NFκB (p65) overexpression, activation, or inhibition, as well as results from the dual-luciferase reporter assay, collectively support our hypothesis. To date, the influence of HP infection on ONECUT2 expression via alternative pathways has not been investigated.
Tumor progression is closely linked to cancer stem cell activity, which can stimulate tumorigenesis through the reorganization of their neighboring niches [41, 42]. Several studies have highlighted the role of ONECUT2 in regulating stemness in various malignant tumors and, in turn, influencing their progression [25, 43]. Similarly, in the context of GC, our results indicated that ONECUT2 promotes GC cell stemness, a process linked to AKT signaling. As Li summarized, PI3K/AKT signaling, as well as TGF-β, Wnt/β-catenin and Notch are important oncogenic pathways that can induce cancer cell stemness, possibly through the activation of epithelial–mesenchymal transition (EMT) [44]. Studies have shown that AKT is dephosphorylated by PP2A and pleckstrin homology domain-containing leucine-rich repeat phosphatases. Although PP2A predominantly dephosphorylates Thr308 of AKT, it also targets Ser473 under certain conditions [45]. Our data further suggests that ONECUT2 may downregulate PP2A phosphorylation, thereby promoting AKT phosphorylation at S473. The ONECUT2 promoter has potential binding sites for the PP2A regulatory subunit PPP2R4, which assists in the biosynthesis of PP2A complexes [46]. Thus, we hypothesized that ONECUT2 may inhibit the transcriptional activity of the PP2A regulatory subunit PPP2R4, decreasing the presence of PP2A complexes and the subsequent downregulation of PP2A phosphorylation. This relieved the dephosphorylation pressure on the AKT substrate, culminating in increased AKT phosphorylation at S473.
Previous studies have shown that Wnt/β-catenin signaling can convert HP-infected gastric epithelial cells into stem-like progenitor cells that promote gland expansion and growth [47,48,49]. Owing to its ability to manipulate the progenitor and stem cell zones, HP colonization can activate stem cells, increase their populations, accelerate the proliferation of Lgr5(+) stem cells, and induce the expression of stem cell-related genes. These actions lead to changes in metabolic dynamics and glandular hyperplasia [48, 50]. The ability of Lgr4 to regulate Lgr5 expression is critical for HP-induced glandular hyperplasia and inflammation [51]. Our experiments further suggest that AKT phosphorylation at S473 enhances β-catenin phosphorylation at S552, allowing β-catenin to enter the nucleus and stimulate expression of stemness-associated genes, including SOX2, SOX9, CD44, and LGR4. This process ultimately modulates GC cell stemness. Whether cell stemness is related to EMT deserves further study. Taken together with the results of HP infection in ONECUT2 downregulated GC cells, we postulate that HP-induced upregulation of ONECUT2 promotes GC cell stemness via the PPP2R4/AKT/β-catenin signaling pathway, thereby promoting GC development.
In conclusion, our comprehensive study demonstrated the significant role of ONECUT2 in promoting HP infection-associated GC and revealed the underlying mechanisms. HP-induced upregulation of ONECUT2 enhances GC cell stemness via PPP2R4/AKT/β-catenin signaling, thereby promoting GC development (Fig. 7). The complex regulatory relationships among HP infection, ONECUT2, and GC require further investigation. These findings suggest promising therapeutic strategies and novel targets for GC.
Data availability
The data generated in this study are publicly available in the Genome Sequence Archive (GSA) database (accession numbers: HRA005558 and HRA005585) and the GEO database (GSE267263). The public data analyzed in this study were obtained from the NCI (https://portal.gdc.cancer.gov/) and the Gene Expression Omnibus (GEO) database (www.ncbi.n1m.nih.gov/gds/). All the other raw data generated in this study are available upon request from the corresponding author.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48.
Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70:1430–40.
Cai Q, Shi P, Yuan Y, Peng J, Ou X, Zhou W, et al. Inflammation-associated senescence promotes helicobacter pylori-induced atrophic gastritis. Cell Mol Gastroenterol Hepatol. 2021;11:857–80.
Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:451–67.
Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflamm Res. 2021;70:1015–26.
Echizen K, Oshima H, Nakayama M, Oshima M. The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion. Adv Biol Regul. 2018;68:39–45.
Busada JT, Peterson KN, Khadka S, Xu X, Oakley RH, Cook DN, et al. Glucocorticoids and androgens protect from gastric metaplasia by suppressing group 2 innate lymphoid cell activation. Gastroenterol. 2021;161:637–652.e4.
Zhang S, Yang X, Wang L, Zhang C. Interplay between inflammatory tumor microenvironment and cancer stem cells. Oncol Lett. 2018;16:679–86.
Echizen K, Hirose O, Maeda Y, Oshima M. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107:391–7.
Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–60.
Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev. Cancer. 2010;10:403–14.
Santos JC, Ribeiro ML. Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol. 2015;21:9021–37.
Alonso-Curbelo D, Ho YJ, Burdziak C, Maag JLV, Morris JP 4th, Chandwani R, et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature. 2021;590:642–8.
Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2:S4–11.
Fattahi S, Kosari-Monfared M, Ghadami E, Golpour M, Khodadadi P, Ghasemiyan M, et al. Infection-associated epigenetic alterations in gastric cancer: New insight in cancer therapy. J Cell Physiol. 2018;233:9261–70.
Jacquemin P, Lannoy VJ, Rousseau GG, Lemaigre FP. OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6. J Biol Chem. 1999;274:2665–71.
Dusing MR, Maier EA, Aronow BJ, Wiginton DA. Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine. Physiol Genomics. 2010;42:115–25.
Maier EA, Dusing MR, Wiginton DA. Temporal regulation of enhancer function in intestinal epithelium: a role for Onecut factors. J Biol Chem. 2006;281:32263–71.
Margagliotti S, Clotman F, Pierreux CE, Beaudry JB, Jacquemin P, Rousseau GG, et al. The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol. 2007;311:579–89.
Clotman F, Jacquemin P, Plumb-Rudewiez N, Pierreux CE, Van der Smissen P, Dietz HC, et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev. 2005;19:1849–54.
Goetz JJ, Martin GM, Chowdhury R, Trimarchi JM. Onecut1 and Onecut2 play critical roles in the development of the mouse retina. PLoS One. 2014;9:e110194.
Sapkota D, Chintala H, Wu F, Fliesler SJ, Hu Z, Mu X. Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. Proc Natl Acad Sci USA. 2014;111:E4086–95.
Pu Y, Li C, Yuan H, Wang X. Identification of prostate cancer-specific methylation biomarkers from a multi-cancer analysis. BMC Bioinformatics. 2021;22:492.
Shen M, Dong C, Ruan X, Yan W, Cao M, Pizzo D, et al. Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2. Cancer Res. 2019;79:3608–21.
Liu D, Zhang T, Chen X, Zhang B, Wang Y, Xie M, et al. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell Death Dis. 2021;12:1113.
Cao L, Zhu S, Lu H, Soutto M, Bhat N, Chen Z, et al. Helicobacter pylori-induced RASAL2 through activation of nuclear factor-κB promotes gastric tumorigenesis via β-catenin signaling axis. Gastroenterol. 2022;162:1716–1731.e17.
Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat Commun. 2019;10:278.
Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med. 2018;24:1887–98.
Ranković B, Zidar N, Žlajpah M, Boštjančič E. Epithelial-mesenchymal transition-related microRNAs and their target genes in colorectal cancerogenesis. J Clin Med 2019;8:1603.
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu Z, et al. MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma. Mol Cell Biochem. 2014;390:19–30.
Ma Q, Wu K, Li H, Li H, Zhu Y, Hu G, et al. ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression. Sci Rep. 2019;9:20021.
Hu J, Chen Y, Li X, Miao H, Li R, Chen D, et al. THUMPD3-AS1 is correlated with non-small cell lung cancer and regulates self-renewal through miR-543 and ONECUT2. Onco Targets Ther. 2019;12:9849–60.
Wang GH, Zhou YM, Yu Z, Deng JP, Liu SF, Wei CZ, et al. Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, invasion, epithelial-mesenchymal transition and tumor growth in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24:9378–90.
Seo EH, Kim HJ, Kim JH, Lim B, Park JL, Kim SY, et al. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5. Int J Cancer. 2020;146:3354–68.
Maubach G, Vieth M, Boccellato F, Naumann M. Helicobacter pylori-induced NF-κB: trailblazer for gastric pathophysiology. Trends Mol Med. 2022;28:210–22.
Lim MCC, Maubach G, Birkl-Toeglhofer AM, Haybaeck J, Vieth M, Naumann M. A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. Cell Mol Life Sci. 2022;79:102.
Qadri Q, Rasool R, Gulzar GM, Naqash S, Shah ZA. H. pylori infection, inflammation and gastric cancer. J Gastrointest Cancer. 2014;45:126–32.
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
Dorrington MG, Fraser IDC. NF-κB signaling in macrophages: dynamics, crosstalk, and signal integration. Front Immunol. 2019;10:705.
Yin W, Wang J, Jiang L, James K Y. Cancer and stem cells. Exp Biol Med (Maywood). 2021;246:1791–801.
Osman A, Afify SM, Hassan G, Fu X, Seno A, Seno M. Revisiting cancer stem cells as the origin of cancer-associated cells in the tumor microenvironment: a hypothetical view from the potential of iPSCs. Cancers (Basel) 2020;12:879.
Yu J, Li D, Jiang H. Emerging role of ONECUT2 in tumors. Oncol Lett. 2020;20:328.
Li D, Xia L, Huang P, Wang Z, Guo Q, Huang C, et al. Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms. Cell Prolif. 2023;56:e13423.
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307:1098–101.
Fevga C, Tesson C, Carreras Mascaro A, Courtin T, van Coller R, Sakka S, et al. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability. Brain. 2023;146:1496–510.
Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, et al. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016;374:292–303.
Cai C, Zhu X. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Mol Med Rep. 2012;5:1191–6.
Sigal M, Logan CY, Kapalczynska M, Mollenkopf HJ, Berger H, Wiedenmann B, et al. Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. Nature. 2017;548:451–5.
Sigal M, Reinés MDM, Müllerke S, Fischer C, Kapalczynska M, Berger H, et al. R-spondin-3 induces secretory, antimicrobial Lgr5(+) cells in the stomach. Nat Cell Biol. 2019;21:812–23.
Wizenty J, Müllerke S, Kolesnichenko M, Heuberger J, Lin M, Fischer AS, et al. Gastric stem cells promote inflammation and gland remodeling in response to Helicobacter pylori via Rspo3-Lgr4 axis. Embo j. 2022;41:e109996.
Acknowledgements
We appreciate the technical support from the Public Technology Service Center of Fujian Medical University and the helpful comments and suggestions from members of the Key Laboratory of the Ministry of Education for Gastrointestinal Cancer.
Funding
This project was funded by the Natural Science Foundation of Fujian Province, China (Grant No.: 2021J01749), Fujian Medical University Union Hospital Talent Launch Fund Project (Grant No.: 2024XH025), the China Scholarship Council (202108350068), Fujian Research and Training Grants for Young- and Middle-aged Leaders in Healthcare [No. (2022)954], the third batch of the Fujian Innovation Star Talent Project [No. (2022)22], and the Excellent Young Scholar Cultivation Project of Fujian Medical University Union Hospital (Grant No.: 2022XH022).
Author information
Authors and Affiliations
Contributions
Lin M, Tu RH, Huang CM, Cao LL, and Li P conceived the study; Lin M, Tu RH, Wu SZ, Zhong Q, and Cao LL conducted the experiments, collected the data, and helped prepare the manuscript; and Weng K and Wu YK conducted the experiments and collected the data. Zhong Q, Lin GT, Wang JB, Lin JX, and Chen QY helped collect the data; Zheng CH, Xie JW, Huang CM, and Li P helped critically revise the manuscript for important intellectual content; all authors have read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This research involving human material or human data is in accordance with the Declaration of Helsinki. Human gastric carcinoma samples were collected from the Fujian Medical University Union Hospital, China. Written informed consent was obtained from all the participants. This study’s design and reporting procedures were approved by the Institutional Review Board of Fujian Medical University Union Hospital (IRB number:2021KJT028-01). Mice were maintained at the Fujian Medical University animal facility in accordance with institutional guidelines. Ethical approval was obtained from the Fujian Medical University Animal Conservation and Use Committee (FJMU IACUC 2021-J-0065).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Massimiliano Agostini
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lin, M., Tu, RH., Wu, SZ. et al. Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. Cell Death Dis 15, 497 (2024). https://doi.org/10.1038/s41419-024-06885-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-024-06885-2
- Springer Nature Limited